{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T04:29:06Z","timestamp":1745987346565,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM19\/00066"],"award-info":[{"award-number":["CM19\/00066"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00415-022-11125-8","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T07:18:04Z","timestamp":1650352684000},"page":"4853-4862","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Progressive cognitive impairment and familial spastic paraparesis due to PRESENILIN 1 mutation: anatomoclinical characterization"],"prefix":"10.1007","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9709-5314","authenticated-orcid":false,"given":"Miren","family":"Altuna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Larumbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Victoria","family":"Zelaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sira","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Garc\u00eda-Solaesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maite","family":"Mendioroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Antonia","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9707-4190","authenticated-orcid":false,"given":"Mar\u00eda Elena","family":"Erro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"key":"11125_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC et al (2021) Alzheimer disease. Nat Rev Dis Prim 7:33. https:\/\/doi.org\/10.1038\/s41572-021-00269-y","journal-title":"Nat Rev Dis Prim"},{"key":"11125_CR2","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2147\/CIA.S105769","volume":"11","author":"M Giri","year":"2016","unstructured":"Giri M, Zhang M, L\u00fc Y (2016) Genes associated with Alzheimer\u2019s disease: an overview and current status. Clin Interv Aging 11:665\u2013681. https:\/\/doi.org\/10.2147\/CIA.S105769","journal-title":"Clin Interv Aging"},{"key":"11125_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1212\/CON.0000000000000687","volume":"25","author":"MF Mendez","year":"2019","unstructured":"Mendez MF (2019) Early-onset Alzheimer Disease and its variants. Continuum (Minneap Minn) 25:34\u201351. https:\/\/doi.org\/10.1212\/CON.0000000000000687","journal-title":"Continuum (Minneap Minn)"},{"key":"11125_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11910-020-01090-y","volume":"21","author":"T Ayodele","year":"2021","unstructured":"Ayodele T, Rogaeva E, Kurup JT et al (2021) Early-onset Alzheimer\u2019s disease: what is missing in research? Curr Neurol Neurosci Rep 21:4. https:\/\/doi.org\/10.1007\/s11910-020-01090-y","journal-title":"Curr Neurol Neurosci Rep"},{"key":"11125_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/gim.2015.117","volume":"18","author":"C Van Cauwenberghe","year":"2016","unstructured":"Van Cauwenberghe C, Van Broeckhoven C, Sleegers K (2016) The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med 18:421\u2013430. https:\/\/doi.org\/10.1038\/gim.2015.117","journal-title":"Genet Med"},{"key":"11125_CR6","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s00702-015-1450-0","volume":"122","author":"S Roeber","year":"2015","unstructured":"Roeber S, M\u00fcller-Sarnowski F, Kress J et al (2015) Three novel presenilin 1 mutations marking the wide spectrum of age at onset and clinical patterns in familial Alzheimer\u2019s disease. J Neural Transm 122:1715\u20131719. https:\/\/doi.org\/10.1007\/s00702-015-1450-0","journal-title":"J Neural Transm"},{"key":"11125_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.nbd.2017.04.020","volume":"104","author":"K Le Guennec","year":"2017","unstructured":"Le Guennec K, Veugelen S, Quenez O et al (2017) Deletion of exons 9 and 10 of the Presenilin 1 gene in a patient with Early-onset Alzheimer Disease generates longer amyloid seeds. Neurobiol Dis 104:97\u2013103. https:\/\/doi.org\/10.1016\/j.nbd.2017.04.020","journal-title":"Neurobiol Dis"},{"key":"11125_CR8","doi-asserted-by":"publisher","first-page":"213.e7","DOI":"10.1016\/j.neurobiolaging.2017.04.017","volume":"56","author":"M Gallo","year":"2017","unstructured":"Gallo M, Frangipane F, Cupidi C et al (2017) The novel PSEN1 M84V mutation associated to frontal dysexecutive syndrome, spastic paraparesis, and cerebellar atrophy in a dominant Alzheimer\u2019s disease family. Neurobiol Aging 56:213.e7-213.e12. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.04.017","journal-title":"Neurobiol Aging"},{"key":"11125_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1468-1331.2009.02810.x","volume":"17","author":"I Uttner","year":"2010","unstructured":"Uttner I, Kirchheiner J, Tumani H et al (2010) A novel presenilin1 mutation (Q223R) associated with early onset Alzheimer\u2019s disease, dysarthria and spastic paraparesis and decreased Abeta levels in CSF. Eur J Neurol 17:631\u2013633. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02810.x","journal-title":"Eur J Neurol"},{"key":"11125_CR10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1177\/1533317509341464","volume":"24","author":"L Dintchov Traykov","year":"2009","unstructured":"Dintchov Traykov L, Mehrabian S, Van den Broeck M et al (2009) Novel PSEN1 mutation in a Bulgarian patient with very early-onset Alzheimer\u2019s disease, spastic paraparesis, and extrapyramidal signs. Am J Alzheimers Dis Other Demen 24:404\u2013407. https:\/\/doi.org\/10.1177\/1533317509341464","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"11125_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1073\/pnas.1619574114","volume":"114","author":"RJ Kelleher 3rd","year":"2017","unstructured":"Kelleher RJ 3rd, Shen J (2017) Presenilin-1 mutations and Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 114:629\u2013631. https:\/\/doi.org\/10.1073\/pnas.1619574114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11125_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12155","volume":"13","author":"J Hoogmartens","year":"2021","unstructured":"Hoogmartens J, Cacace R, Van Broeckhoven C (2021) Insight into the genetic etiology of Alzheimer\u2019s disease: A comprehensive review of the role of rare variants. Alzheimer\u2019s Dement (Amsterdam, Netherlands) 13:e12155. https:\/\/doi.org\/10.1002\/dad2.12155","journal-title":"Alzheimer\u2019s Dement (Amsterdam, Netherlands)"},{"key":"11125_CR13","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3233\/JAD-200598","volume":"77","author":"CA Deaton","year":"2020","unstructured":"Deaton CA, Johnson GVW (2020) Presenilin 1 regulates membrane homeostatic pathways that are dysregulated in Alzheimer\u2019s Disease. J Alzheimers Dis 77:961\u2013977. https:\/\/doi.org\/10.3233\/JAD-200598","journal-title":"J Alzheimers Dis"},{"key":"11125_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3233\/JAD-130746","volume":"37","author":"AJ Larner","year":"2013","unstructured":"Larner AJ (2013) Presenilin-1 mutations in Alzheimer\u2019s disease: an update on genotype-phenotype relationships. J Alzheimers Dis 37:653\u2013659. https:\/\/doi.org\/10.3233\/JAD-130746","journal-title":"J Alzheimers Dis"},{"key":"11125_CR15","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S1474-4422(10)70159-9","volume":"9","author":"MN Rossor","year":"2010","unstructured":"Rossor MN, Fox NC, Mummery CJ et al (2010) The diagnosis of young-onset dementia. Lancet Neurol 9:793\u2013806. https:\/\/doi.org\/10.1016\/S1474-4422(10)70159-9","journal-title":"Lancet Neurol"},{"key":"11125_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2217\/bmm.09.92","volume":"4","author":"NS Ryan","year":"2010","unstructured":"Ryan NS, Rossor MN (2010) Correlating familial Alzheimer\u2019s disease gene mutations with clinical phenotype. Biomark Med 4:99\u2013112. https:\/\/doi.org\/10.2217\/bmm.09.92","journal-title":"Biomark Med"},{"key":"11125_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jfma.2015.08.004","volume":"115","author":"Y-F Shea","year":"2016","unstructured":"Shea Y-F, Chu L-W, Chan AO-K et al (2016) A systematic review of familial Alzheimer\u2019s disease: Differences in presentation of clinical features among three mutated genes and potential ethnic differences. J Formos Med Assoc 115:67\u201375. https:\/\/doi.org\/10.1016\/j.jfma.2015.08.004","journal-title":"J Formos Med Assoc"},{"key":"11125_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002270","volume":"14","author":"H-M Lanoisel\u00e9e","year":"2017","unstructured":"Lanoisel\u00e9e H-M, Nicolas G, Wallon D et al (2017) APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases. PLoS Med 14:e1002270. https:\/\/doi.org\/10.1371\/journal.pmed.1002270","journal-title":"PLoS Med"},{"key":"11125_CR19","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1001\/archneur.62.12.1821","volume":"62","author":"BJ Snider","year":"2005","unstructured":"Snider BJ, Norton J, Coats MA et al (2005) Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life. Arch Neurol 62:1821\u20131830. https:\/\/doi.org\/10.1001\/archneur.62.12.1821","journal-title":"Arch Neurol"},{"key":"11125_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/WAD.0b013e3181732399","volume":"22","author":"LA Rudzinski","year":"2008","unstructured":"Rudzinski LA, Fletcher RM, Dickson DW et al (2008) Early onset familial Alzheimer Disease with spastic paraparesis, dysarthria, and seizures and N135S mutation in PSEN1. Alzheimer Dis Assoc Disord 22:299\u2013307. https:\/\/doi.org\/10.1097\/WAD.0b013e3181732399","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"11125_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.expneurol.2006.01.022","volume":"200","author":"C Zekanowski","year":"2006","unstructured":"Zekanowski C, Golan MP, Krzy\u015bko KA et al (2006) Two novel presenilin 1 gene mutations connected with frontotemporal dementia-like clinical phenotype: genetic and bioinformatic assessment. Exp Neurol 200:82\u201388. https:\/\/doi.org\/10.1016\/j.expneurol.2006.01.022","journal-title":"Exp Neurol"},{"key":"11125_CR22","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/s0002-9440(10)64688-3","volume":"158","author":"DM Mann","year":"2001","unstructured":"Mann DM, Pickering-Brown SM, Takeuchi A, Iwatsubo T (2001) Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer\u2019s disease. Am J Pathol 158:2165\u20132175. https:\/\/doi.org\/10.1016\/s0002-9440(10)64688-3","journal-title":"Am J Pathol"},{"key":"11125_CR23","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/S1474-4422(16)30229-0","volume":"15","author":"M Tang","year":"2016","unstructured":"Tang M, Ryman DC, McDade E et al (2016) Neurological manifestations of autosomal dominant familial Alzheimer\u2019s disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). Lancet Neurol 15:1317\u20131325. https:\/\/doi.org\/10.1016\/S1474-4422(16)30229-0","journal-title":"Lancet Neurol"},{"key":"11125_CR24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nm0498-452","volume":"4","author":"R Crook","year":"1998","unstructured":"Crook R, Verkkoniemi A, Perez-Tur J et al (1998) A variant of Alzheimer\u2019s disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med 4:452\u2013455. https:\/\/doi.org\/10.1038\/nm0498-452","journal-title":"Nat Med"},{"key":"11125_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-009-0521-4","volume":"118","author":"C Shepherd","year":"2009","unstructured":"Shepherd C, McCann H, Halliday GM (2009) Variations in the neuropathology of familial Alzheimer\u2019s disease. Acta Neuropathol 118:37\u201352. https:\/\/doi.org\/10.1007\/s00401-009-0521-4","journal-title":"Acta Neuropathol"},{"key":"11125_CR26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/jnen\/nlv028","volume":"75","author":"JM Ringman","year":"2016","unstructured":"Ringman JM, Monsell S, Ng DW et al (2016) Neuropathology of autosomal dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database. J Neuropathol Exp Neurol 75:284\u2013290. https:\/\/doi.org\/10.1093\/jnen\/nlv028","journal-title":"J Neuropathol Exp Neurol"},{"key":"11125_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1440-1789.2012.01340.x","volume":"33","author":"A Niwa","year":"2013","unstructured":"Niwa A, Matsuo K, Shindo A et al (2013) Clinical and neuropathological findings in a patient with familial Alzheimer disease showing a mutation in the PSEN1 gene. Neuropathology 33:199\u2013203. https:\/\/doi.org\/10.1111\/j.1440-1789.2012.01340.x","journal-title":"Neuropathology"},{"key":"11125_CR28","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/archneur.63.3.370","volume":"63","author":"JB Leverenz","year":"2006","unstructured":"Leverenz JB, Fishel MA, Peskind ER et al (2006) Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype. Arch Neurol 63:370\u2013376. https:\/\/doi.org\/10.1001\/archneur.63.3.370","journal-title":"Arch Neurol"},{"key":"11125_CR29","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.jalz.2017.03.007","volume":"13","author":"M Carmona-Iragui","year":"2017","unstructured":"Carmona-Iragui M, Balasa M, Benejam B et al (2017) Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer\u2019s disease. Alzheimers Dement 13:1251\u20131260. https:\/\/doi.org\/10.1016\/j.jalz.2017.03.007","journal-title":"Alzheimers Dement"},{"key":"11125_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fnana.2015.00025","volume":"9","author":"ME Erro Aguirre","year":"2015","unstructured":"Erro Aguirre ME, Zelaya MV, Ruiz S, de Gordoa J et al (2015) Midbrain catecholaminergic neurons co-express \u03b1-synuclein and tau in progressive supranuclear palsy. Front Neuroanat 9:25. https:\/\/doi.org\/10.3389\/fnana.2015.00025","journal-title":"Front Neuroanat"},{"key":"11125_CR31","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/mp.2015.100","volume":"20","author":"A Rovelet-Lecrux","year":"2015","unstructured":"Rovelet-Lecrux A, Charbonnier C, Wallon D et al (2015) De novo deleterious genetic variations target a biological network centered on A\u03b2 peptide in early-onset Alzheimer disease. Mol Psychiatry 20:1046\u20131056. https:\/\/doi.org\/10.1038\/mp.2015.100","journal-title":"Mol Psychiatry"},{"key":"11125_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311. https:\/\/doi.org\/10.1007\/s00401-011-0910-3","journal-title":"Acta Neuropathol"},{"key":"11125_CR33","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-008-0366-2","volume":"115","author":"DR Thal","year":"2008","unstructured":"Thal DR, Griffin WST, de Vos RAI, Ghebremedhin E (2008) Cerebral amyloid angiopathy and its relationship to Alzheimer\u2019s disease. Acta Neuropathol 115:599\u2013609. https:\/\/doi.org\/10.1007\/s00401-008-0366-2","journal-title":"Acta Neuropathol"},{"key":"11125_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW et al (2017) Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89:88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058","journal-title":"Neurology"},{"key":"11125_CR35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/00001756-199512000-00071","volume":"7","author":"J Perez-Tur","year":"1995","unstructured":"Perez-Tur J, Froelich S, Prihar G et al (1995) A mutation in Alzheimer\u2019s disease destroying a splice acceptor site in the presenilin-1 gene. NeuroReport 7:297\u2013301","journal-title":"NeuroReport"},{"key":"11125_CR36","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/humu.9458","volume":"27","author":"C Dumanchin","year":"2006","unstructured":"Dumanchin C, Tournier I, Martin C et al (2006) Biological effects of four PSEN1 gene mutations causing Alzheimer disease with spastic paraparesis and cotton wool plaques. Hum Mutat 27:1063. https:\/\/doi.org\/10.1002\/humu.9458","journal-title":"Hum Mutat"},{"key":"11125_CR37","doi-asserted-by":"publisher","first-page":"7615","DOI":"10.1074\/jbc.274.12.7615","volume":"274","author":"H Steiner","year":"1999","unstructured":"Steiner H, Romig H, Grim MG et al (1999) The biological and pathological function of the presenilin-1 Deltaexon 9 mutation is independent of its defect to undergo proteolytic processing. J Biol Chem 274:7615\u20137618. https:\/\/doi.org\/10.1074\/jbc.274.12.7615","journal-title":"J Biol Chem"},{"key":"11125_CR38","doi-asserted-by":"publisher","unstructured":"Appel-Cresswell S, Guella I, Lehman A, et al (2018) PSEN1 p.Met233Val in a Complex Neurodegenerative Movement and Neuropsychiatric Disorder. J Mov Disord 11:45\u201348. https:\/\/doi.org\/10.14802\/jmd.17066","DOI":"10.14802\/jmd.17066"},{"key":"11125_CR39","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1471-4159.2007.05038.x","volume":"104","author":"H Karlstrom","year":"2008","unstructured":"Karlstrom H, Brooks WS, Kwok JBJ et al (2008) Variable phenotype of Alzheimer\u2019s disease with spastic paraparesis. J Neurochem 104:573\u2013583. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05038.x","journal-title":"J Neurochem"},{"key":"11125_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12186","volume":"13","author":"V Chelban","year":"2021","unstructured":"Chelban V, Breza M, Szaruga M et al (2021) Spastic paraplegia preceding PSEN1-related familial Alzheimer\u2019s disease. Alzheimer\u2019s Dement (Amsterdam, Netherlands) 13:e12186. https:\/\/doi.org\/10.1002\/dad2.12186","journal-title":"Alzheimer\u2019s Dement (Amsterdam, Netherlands)"},{"key":"11125_CR41","doi-asserted-by":"publisher","first-page":"540","DOI":"10.2174\/1567205017666200624195809","volume":"17","author":"J Zhou","year":"2020","unstructured":"Zhou J, Chen Y, Meng F et al (2020) Presenilin 1 and APP gene mutations in early-onset AD families from a Southeast region of China. Curr Alzheimer Res 17:540\u2013546. https:\/\/doi.org\/10.2174\/1567205017666200624195809","journal-title":"Curr Alzheimer Res"},{"key":"11125_CR42","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TLS et al (2012) Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med 367:795\u2013804. https:\/\/doi.org\/10.1056\/NEJMoa1202753","journal-title":"N Engl J Med"},{"key":"11125_CR43","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","volume":"10","author":"RL Hamilton","year":"2000","unstructured":"Hamilton RL (2000) Lewy bodies in Alzheimer\u2019s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 10:378\u2013384. https:\/\/doi.org\/10.1111\/j.1750-3639.2000.tb00269.x","journal-title":"Brain Pathol"},{"key":"11125_CR44","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/jnen\/nlz039","volume":"78","author":"DD Gondim","year":"2019","unstructured":"Gondim DD, Oblak A, Murrell JR et al (2019) Diffuse Lewy Body disease and Alzheimer disease: neuropathologic phenotype associated with the PSEN1 p. A396T mutation. J Neuropathol Exp Neurol 78:585\u2013594. https:\/\/doi.org\/10.1093\/jnen\/nlz039","journal-title":"J Neuropathol Exp Neurol"},{"key":"11125_CR45","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1001\/archneurol.2009.196","volume":"66","author":"F Portet","year":"2009","unstructured":"Portet F, Scarmeas N, Cosentino S et al (2009) Extrapyramidal signs before and after diagnosis of incident Alzheimer disease in a prospective population study. Arch Neurol 66:1120\u20131126. https:\/\/doi.org\/10.1001\/archneurol.2009.196","journal-title":"Arch Neurol"},{"key":"11125_CR46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","volume":"14","author":"D Twohig","year":"2019","unstructured":"Twohig D, Nielsen HM (2019) \u03b1-synuclein in the pathophysiology of Alzheimer\u2019s disease. Mol Neurodegener 14:23. https:\/\/doi.org\/10.1186\/s13024-019-0320-x","journal-title":"Mol Neurodegener"},{"key":"11125_CR47","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1212\/wnl.51.2.351","volume":"51","author":"JM Olichney","year":"1998","unstructured":"Olichney JM, Galasko D, Salmon DP et al (1998) Cognitive decline is faster in Lewy body variant than in Alzheimer\u2019s disease. Neurology 51:351\u2013357. https:\/\/doi.org\/10.1212\/wnl.51.2.351","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11125-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11125-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11125-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T15:09:07Z","timestamp":1660057747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11125-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["11125"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11125-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"type":"print","value":"0340-5354"},{"type":"electronic","value":"1432-1459"}],"subject":[],"published":{"date-parts":[[2022,4,19]]},"assertion":[{"value":"17 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors declare any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The patients included in this study signed the corresponding informed consent form approved by the ethics committee of the University Hospital of Navarra. The study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}